Annual Short Term Debt
$2.65 M
+$279.00 K+11.78%
31 December 2023
Summary:
BioCryst Pharmaceuticals annual short term debt is currently $2.65 million, with the most recent change of +$279.00 thousand (+11.78%) on 31 December 2023. During the last 3 years, it has risen by +$829.00 thousand (+45.57%). BCRX annual short term debt is now -93.37% below its all-time high of $39.96 million, reached on 31 December 2019.BCRX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$2.89 M
+$181.00 K+6.69%
30 September 2024
Summary:
BioCryst Pharmaceuticals quarterly short term debt is currently $2.89 million, with the most recent change of +$181.00 thousand (+6.69%) on 30 September 2024. Over the past year, it has increased by +$240.00 thousand (+9.06%). BCRX quarterly short term debt is now -94.22% below its all-time high of $49.96 million, reached on 30 September 2020.BCRX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCRX Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +9.1% |
| 3 y3 years | +45.6% | +58.8% |
| 5 y5 years | -93.4% | -92.8% |
BCRX Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -91.5% | +45.6% | -90.8% | +58.8% |
| 5 y | 5 years | -93.4% | +45.6% | -94.2% | +58.8% |
| alltime | all time | -93.4% | -94.2% |
BioCryst Pharmaceuticals Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.89 M(+6.7%) |
| June 2024 | - | $2.71 M(-1.2%) |
| Mar 2024 | - | $2.74 M(+3.5%) |
| Dec 2023 | $2.65 M(+11.8%) | $2.65 M(+16.0%) |
| Sept 2023 | - | $2.28 M(-9.8%) |
| June 2023 | - | $2.53 M(+1.6%) |
| Mar 2023 | - | $2.49 M(+5.1%) |
| Dec 2022 | $2.37 M(+30.2%) | $2.37 M(+7.9%) |
| Sept 2022 | - | $2.20 M(+2.9%) |
| June 2022 | - | $2.13 M(+2.5%) |
| Mar 2022 | - | $2.08 M(+14.4%) |
| Dec 2021 | $1.82 M(-94.2%) | $1.82 M(-94.2%) |
| Sept 2021 | - | $31.45 M(+1.5%) |
| June 2021 | - | $30.98 M(-0.1%) |
| Mar 2021 | - | $31.00 M(-0.6%) |
| Dec 2020 | $31.18 M(-22.0%) | $31.18 M(-37.6%) |
| Sept 2020 | - | $49.96 M(+0.1%) |
| June 2020 | - | $49.93 M(+11.0%) |
| Mar 2020 | - | $45.00 M(+12.6%) |
| Dec 2019 | $39.96 M(+18.4%) | $39.96 M(+14.4%) |
| Sept 2019 | - | $34.94 M(+19.1%) |
| June 2019 | - | $29.34 M(+0.4%) |
| Mar 2019 | - | $29.23 M(-13.4%) |
| Dec 2018 | $33.75 M(-4.2%) | $33.75 M(+9.9%) |
| Sept 2018 | - | $30.70 M(-13.5%) |
| June 2018 | - | $35.51 M(+0.4%) |
| Mar 2018 | - | $35.37 M(+0.4%) |
| Dec 2017 | $35.22 M(+24.7%) | $35.22 M(+5.5%) |
| Sept 2017 | - | $33.37 M(+6.1%) |
| June 2017 | - | $31.46 M(+6.2%) |
| Mar 2017 | - | $29.63 M(+4.9%) |
| Dec 2016 | $28.24 M | $28.24 M(+0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2016 | - | $28.13 M(+0.4%) |
| June 2016 | - | $28.02 M(+0.4%) |
| Mar 2016 | - | $27.91 M(+0.4%) |
| Dec 2015 | $27.80 M(-7.3%) | $27.80 M(-7.3%) |
| Sept 2015 | - | $30.00 M(0.0%) |
| June 2015 | - | $30.00 M(0.0%) |
| Mar 2015 | - | $30.00 M(0.0%) |
| Dec 2014 | $30.00 M(>+9900.0%) | $30.00 M(0.0%) |
| Sept 2014 | - | $30.00 M(0.0%) |
| June 2014 | - | $30.00 M(>+9900.0%) |
| Dec 2013 | $0.00(-100.0%) | $0.00(-100.0%) |
| Mar 2001 | - | $3000.00(-69.4%) |
| Dec 2000 | $9800.00(-90.2%) | $9800.00(-42.4%) |
| Sept 2000 | - | $17.00 K(-26.1%) |
| June 2000 | - | $23.00 K(-12.5%) |
| Mar 2000 | - | $26.30 K(-73.7%) |
| Dec 1997 | $100.00 K(-50.0%) | $100.00 K(0.0%) |
| Sept 1997 | - | $100.00 K(0.0%) |
| June 1997 | - | $100.00 K(-50.0%) |
| Mar 1997 | - | $200.00 K(0.0%) |
| Dec 1996 | $200.00 K(-33.3%) | $200.00 K(-33.3%) |
| Sept 1996 | - | $300.00 K(0.0%) |
| June 1996 | - | $300.00 K(0.0%) |
| Mar 1996 | - | $300.00 K(0.0%) |
| Dec 1995 | $300.00 K(0.0%) | $300.00 K(0.0%) |
| Sept 1995 | - | $300.00 K(+50.0%) |
| June 1995 | - | $200.00 K(0.0%) |
| Mar 1995 | - | $200.00 K(-33.3%) |
| Dec 1994 | $300.00 K | $300.00 K(0.0%) |
| Sept 1994 | - | $300.00 K(-25.0%) |
| June 1994 | - | $400.00 K(0.0%) |
| Mar 1994 | - | $400.00 K |
FAQ
- What is BioCryst Pharmaceuticals annual short term debt?
- What is the all time high annual short term debt for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly short term debt year-on-year change?
What is BioCryst Pharmaceuticals annual short term debt?
The current annual short term debt of BCRX is $2.65 M
What is the all time high annual short term debt for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual short term debt is $39.96 M
What is BioCryst Pharmaceuticals quarterly short term debt?
The current quarterly short term debt of BCRX is $2.89 M
What is the all time high quarterly short term debt for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly short term debt is $49.96 M
What is BioCryst Pharmaceuticals quarterly short term debt year-on-year change?
Over the past year, BCRX quarterly short term debt has changed by +$240.00 K (+9.06%)